Symetryx Corp Neu Base Therapeutics, Inc. (NBSE) insider trading activity

NBSE Quotes by TradingView

Symetryx Corp is > 10% Shareholder of NeuBase Therapeutics, Inc.. Currently has a direct ownership of 0 shares of NBSE, which is worth approximately $0. The most recent transaction as insider was on Sep 18, 2023, when has been sold 50,000 shares (Common Stock, par value $0.0001 per share) at a price of $1.19 per share, resulting in proceeds of $59,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Symetryx Corp Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 18 2023
SELL
Open market or private sale
$59,500 $1.19 p/Share
50,000 Reduced 100.0%
0 Common Stock, par valu...
Sep 15 2023
SELL
Open market or private sale
$130,204 $1.26 p/Share
103,337 Reduced 67.39%
50,000 Common Stock, par valu...
Sep 14 2023
SELL
Open market or private sale
$185,915 $1.44 p/Share
129,108 Reduced 45.71%
153,337 Common Stock, par valu...
Sep 11 2023
SELL
Open market or private sale
$4,861 $1.44 p/Share
3,376 Reduced 0.71%
472,926 Common Stock, par valu...
Sep 08 2023
SELL
Open market or private sale
$197,135 $1.53 p/Share
128,847 Reduced 21.29%
476,302 Common Stock, par valu...
Sep 07 2023
SELL
Open market or private sale
$134,733 $1.8 p/Share
74,852 Reduced 11.01%
605,149 Common Stock, par valu...
Sep 01 2023
BUY
Open market or private purchase
$59,854 $0.98 p/Share
61,076 Added 8.24%
680,081 Common Stock, par valu...
SC

Symetryx Corp

> 10% Shareholder
Toronto, A6

Track Institutional and Insider Activities on NBSE

Follow NeuBase Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NBSE shares.

Notify only if

Insider Trading

Get notified when an Neu Base Therapeutics, Inc. insider buys or sells NBSE shares.

Notify only if

News

Receive news related to NeuBase Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NBSE